Description
Operator of a nano and biotechnology platform intended to develop liquid nano-sized drug delivery vehicles. The company's technology creates solubilization of large loads of water-insoluble and poorly-permeable drug molecules as well as bio-macro molecules, enhancing the drug transport across the human membranes, enabling patients to increase compliance and quality of life by offering a drug with reduced side effects and greater convenience.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Jan-2013 | Completed | Clinical Trials - General |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3986383-A1 | Polymeric soft films embedded with nanodomains and/or a bioactive and methods of producing same | Pending | 20-Jun-2019 | 0000000000 | |
US-20220304940-A1 | Polymeric soft films embedded with nanodomains and/or a bioactive and methods of producing same | Pending | 20-Jun-2019 | 0000000000 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sharon Garti-Levi | Co-Founder, Chief Executive Officer & Chief Technology Officer | ||
Nissim Garti | Co-Founder, President & Chief Science |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
8200 EISP | Accelerator/Incubator | 000 0000 | 000000 0 |